ReShape Lifesciences Inc (RSLS) — Strategic Asset Allocation Index
ReShape Lifesciences Inc (RSLS) has a Strategic Asset Allocation Index of 14.2% as of June 2023. Strategic assets (PP&E of $956.00K plus long-term investments of $-) total $956.00K, measured against net assets of $6.74 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See RSLS equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
ReShape Lifesciences Inc Strategic Asset Allocation Index (2005–2022)
This chart shows how ReShape Lifesciences Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2022. As of June 2023, the index stands at 14.2%, representing strategic assets of $956.00K against net assets of $6.74 Million USD. For live market cap and overall valuation, see RSLS company net worth.
Annual Strategic Asset Allocation Index for ReShape Lifesciences Inc (2005–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for ReShape Lifesciences Inc from 2005 to 2022, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See ReShape Lifesciences Inc book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.7% | $869.00K | $869.00K | $- | $3.66 Million | ▲ +20.0 pp |
| 2021 | 3.7% | $1.72 Million | $1.72 Million | $- | $46.07 Million | ▼ -0.3 pp |
| 2020 | 4.0% | $584.00K | $584.00K | $- | $14.49 Million | ▲ +4.0 pp |
| 2019 | 0.1% | $16.00K | $16.00K | $- | $24.11 Million | ▼ -0.1 pp |
| 2018 | 0.2% | $63.55K | $63.55K | $- | $31.66 Million | ▼ -0.4 pp |
| 2017 | 0.6% | $438.62K | $438.62K | $- | $76.37 Million | ▼ -6.3 pp |
| 2016 | 6.8% | $200.72K | $200.72K | $- | $2.94 Million | ▼ -2.1 pp |
| 2015 | 8.9% | $326.30K | $326.30K | $- | $3.67 Million | ▲ +1.7 pp |
| 2014 | 7.2% | $481.52K | $481.52K | $- | $6.66 Million | ▲ +3.3 pp |
| 2013 | 3.9% | $577.00K | $577.00K | $- | $14.68 Million | ▼ -1.2 pp |
| 2012 | 5.1% | $609.67K | $609.67K | $- | $11.88 Million | ▲ +2.0 pp |
| 2011 | 3.1% | $630.35K | $630.35K | $- | $20.04 Million | ▲ +0.6 pp |
| 2010 | 2.5% | $742.00K | $742.00K | $- | $29.71 Million | ▼ -14.8 pp |
| 2009 | 17.3% | $966.00K | $966.00K | $- | $5.58 Million | ▲ +6.2 pp |
| 2008 | 11.1% | $1.26 Million | $1.26 Million | $- | $11.41 Million | ▲ +7.8 pp |
| 2007 | 3.3% | $1.49 Million | $1.49 Million | $- | $45.28 Million | ▼ -0.6 pp |
| 2006 | 3.9% | $1.10 Million | $1.10 Million | $- | $28.57 Million | ▼ -28.7 pp |
| 2005 | 32.5% | $642.00K | $642.00K | $- | $1.97 Million | — |